Introducing Metanova Labs' NOVA: A Decentralized Engine for Drug Discovery on Bittensor Subnet 68

Metanova Labs, a crypto-native biotech company, is revolutionizing drug discovery by leveraging #Bittensor's decentralized network. Their NOVA Subnet 68 ($SN68) harnesses global computing power and collective intelligence to explore vast chemical spaces, aiming to uncover breakthrough compounds efficiently.

Key Features of NOVA:
- Decentralized Drug Screening: NOVA utilizes machine learning-based active learning and heuristic adaptive search methods to navigate extensive chemical databases, such as the SAVI 2020 library containing over 1.75 billion synthesizable compounds.

- Incentive-Driven Participation: The subnet rewards miners for contributing high-quality, diverse, and novel compounds, fostering a competitive environment that accelerates the discovery of promising drug candidates.

- Objective Validation: Submissions are evaluated using PSICHIC, a state-of-the-art model that assigns binding affinity scores, ensuring transparent and objective assessment of contributions.

Collaborate & Build
Metanova Labs is actively seeking collaborators to join their mission in transforming drug discovery. Whether you're a researcher, developer, or data enthusiast, there are numerous opportunities to contribute to this groundbreaking initiative on Bittensor.

Learn More:
🔹 Website:🔹 Whitepaper:🔹 GitHub:🔹 Twitter: @metanova_labs

Metanova Labs is harnessing the power of decentralized AI to push the boundaries of biomedical innovation. Subnet 68 is a glimpse into the future of AI-powered drug discovery.
#Bittensor